Clinical Trial Update: Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating lentiviral gene transfer for treating X-linked severe combined immunodeficiency in children over two years old is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Severe Combined Immunodeficiency

Drugs mentioned

• Lentiviral gene transfer therapy for XSCID

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: X-linked Severe Combined Immunodeficiency (XSCID) | Phase 1, Phase 2 | Status: RECRUITING